Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Status:
Completed
Trial end date:
2016-09-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the efficacy, safety, and tolerability of
fulranumab as Monotherapy compared with placebo in participants with signs and symptoms of
osteoarthritis of the hip or knee that are not adequately controlled by current pain therapy.